Isolate Data
Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
MP570 | 97CM.570 | Cameroon | 1997 | HIV1 | CRF02_AG | PBMC | None |
Treatment History
Order | Regimen | Weeks |
1 | None | NA |
Integrase Sequence
INIMajorDRMs | INIMinorDRMs | Polys | UnusualMuts |
L74M, T97A | K14R, V31I, L101I, T112V, S119T, T124A, T125A, G134N, I135V, K136T, V201I, T206S, L234I |
>97CM.570| codons 1-249 FLDGIDKAQEEHERYHSNWRAMASDFNLPPIVAKEIVASCDKCQLKGEAMHGQVDCSPGI WQLDCTHLEGKIIMVAVHVASGYIEAEVIPAETGQEAAYFILKLAGRWPVKVIHTDNGTN FTSAAVKAACWWANVTQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAV FIHNFKRKGGIGGYSAGERIIDIIASDIQTKELQKQITKIQNFRVYYRDSRDPIWKGPAK LLWKGEGAV |
Protease Sequence
PIMajorDRMs | PIMinorDRMs | Polys | UnusualMuts |
I13V, K14R, K20I, M36T, R41K, I64M, H69K, L89M |
>97CM.570| codons 1-99 PQITLWQRPLVTVRIGGQLIEALLDTGADDTVLEETNLPGKWKPKMIGGIGGFIKVRQYD QILMEICGKKAIGTVLVGPTPVNIIGRNMLTQIGCTLNF |
RT Sequence
NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
V35T, K104R, K122E, D123N, I135V, S162A, K173T, Q174K, D177E, T200A, Q207E, R211K, V245Q, T286A, E291D, V292I, I293V, P294T, L295M, S322T, I326V, G335D, R356K, M357K, G359S, A371V, I375V, K390R, T403L, E432D, V435I, A446S, D471E, Q480H, H483Y, L491S, S519N, Q524K, K527E, E529D, A534S, A554N, K558R, V559I |
>97CM.570| codons 1-560 PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALTEICTEMEKEGKISKIGPENPYNTPV FAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKKRSVTVLDVGDAYFSVPL DENFRKYTAFTIPSVNNETPGIRYQYNVLPQGWKGSPAIFQASMTKILEPFRTKNPEIVI YQYMDDLYVGSDLEIGQHRAKIEELREHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWT VQPIQLPEKDSWTVNDIQKLVGKLNWASQIYAGIKVKQLCKLLRGAKALTDIVTMTEEAE LELAENREILKEPVHGVYYDPTKDLVAEIQKQGQDQWTYQIYQEPFKNLKTGKYAKKRSA HTNDVKQLTEVVQKVATESIVIWGKTPKFRLPIQKETWEAWWLEYWQATWIPEWEFVNTP PLVKLWYQLEKDPIIGAETFYVDGASNRETKLGKAGYVTDRGRQKVVSLTETTNQKTELH AIYLALQDSGSEVNIVTDSQYALGIIQAQPDKSESELVNQIIEKLIEKDKVYLSWVPAHK GIGGNEQVDKLVSNGIRRIL |
References
Author | Title | Citation |
Njai, HF | The predominance of human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness. | Retrovirology, 2006 |